Inflammatory Bowel Diseases
|
0.100 |
GeneticVariation
|
group |
GWASDB |
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
|
23128233 |
2012 |
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1
|
0.920 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene.
|
10647011 |
1999 |
Nephroblastomatosis, fetal ascites, macrosomia and Wilms tumor
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects.
|
23486536 |
2013 |
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1
|
0.920 |
GeneticVariation
|
disease |
UNIPROT |
DNMT3B mutations and DNA methylation defect define two types of ICF syndrome.
|
15580563 |
2005 |
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1
|
0.920 |
GeneticVariation
|
disease |
UNIPROT |
The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome.
|
10588719 |
1999 |
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1
|
0.920 |
GeneticVariation
|
disease |
UNIPROT |
A Novel Mutation in a Critical Region for the Methyl Donor Binding in DNMT3B Causes Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome (ICF).
|
27734333 |
2016 |
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1
|
0.920 |
GeneticVariation
|
disease |
UNIPROT |
Genetic variation in ICF syndrome: evidence for genetic heterogeneity.
|
11102980 |
2000 |
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1
|
0.920 |
GeneticVariation
|
disease |
UNIPROT |
ICF syndrome in Saudi Arabia: immunological, cytogenetic and molecular analysis.
|
21120685 |
2011 |
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1
|
0.920 |
GeneticVariation
|
disease |
UNIPROT |
Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene.
|
10647011 |
1999 |
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1
|
0.920 |
GeneticVariation
|
disease |
UNIPROT |
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.
|
10555141 |
1999 |
FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy.
|
27153398 |
2016 |
Liver carcinoma
|
0.300 |
Biomarker
|
disease |
RGD |
Immunoblot assay showed that the levels of DNMT1, DNMT3a, and DNMT3b proteins in the hepatoma were 5-, 10-, and 4-fold higher, respectively, than in the liver.
|
11844796 |
2002 |
Liver neoplasms
|
0.210 |
Biomarker
|
group |
RGD |
Immunoblot assay showed that the levels of DNMT1, DNMT3a, and DNMT3b proteins in the hepatoma were 5-, 10-, and 4-fold higher, respectively, than in the liver.
|
11844796 |
2002 |
Anxiety Disorders
|
0.200 |
Biomarker
|
group |
RGD |
Gestational hypoxia induces sex-differential methylation of Crhr1 linked to anxiety-like behavior.
|
23529784 |
2013 |
Fetal Growth Retardation
|
0.200 |
Biomarker
|
phenotype |
RGD |
Prenatal caffeine ingestion induces aberrant DNA methylation and histone acetylation of steroidogenic factor 1 and inhibits fetal adrenal steroidogenesis.
|
24717552 |
2014 |
Congenital Heart Defects
|
0.200 |
Biomarker
|
group |
RGD |
Alteration in methylation pattern of GATA-4 promoter region in vitamin A-deficient offspring's heart.
|
23333085 |
2013 |
Mammary Neoplasms, Experimental
|
0.200 |
Therapeutic
|
phenotype |
RGD |
Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue.
|
24447120 |
2014 |
prostatitis
|
0.200 |
Biomarker
|
disease |
RGD |
Vinclozolin exposure in utero induces postpubertal prostatitis and reduces sperm production via a reversible hormone-regulated mechanism.
|
20056826 |
2010 |
Hepatoblastoma
|
0.200 |
Biomarker
|
disease |
RGD |
Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma.
|
11844796 |
2002 |
Malignant neoplasm of liver
|
0.200 |
Biomarker
|
disease |
RGD |
Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma.
|
11844796 |
2002 |
Hepatoblastoma Caused By Somatic Mutation
|
0.200 |
Biomarker
|
disease |
RGD |
Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma.
|
11844796 |
2002 |
Schizophrenia
|
0.320 |
Biomarker
|
disease |
PSYGENET |
DNMT3B rs1569686 (genotype P = 0.027, allele P = 0.033) was found to be associated with early onset of schizophrenia and also with family history and early onset (genotype P = 0.009).
|
24859147 |
2014 |
Mood Disorders
|
0.310 |
Biomarker
|
group |
PSYGENET |
Thus, our data suggest that the altered expression of DNMTs is state dependent and that the aberrant epigenetic gene regulations caused by the altered expression of DNMT1 and DNMT3B may be associated with the pathophysiology of mood disorders.
|
21592522 |
2011 |
Early onset schizophrenia
|
0.310 |
Biomarker
|
disease |
PSYGENET |
In this study, we investigated the association between DNMT3B polymorphisms and the susceptibility of early onset schizophrenia in Chinese Han population.
|
19576953 |
2009 |
Immunologic Deficiency Syndromes
|
0.450 |
Biomarker
|
group |
HPO |
|
|
|